Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.50 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.50 |
| ▸ | HMGCR | P04035 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 4/20 | 0.38 |
| ▸ | SLC13A5 | Q86YT5 | 3/20 | 0.38 |
| ▸ | CPT2 | P23786 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL5322801 | 1.00 | ALDH1A1 (0.75) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL712971 | 0.97 | ALDH1A1 (0.79) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL23529273 | 0.95 | ALDH1A1 (0.75) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL23529090 | 0.95 | ALDH1A1 (0.75) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL27493316 | 0.95 | ALDH1A1 (0.75) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL23529151 | 0.95 | ALDH1A1 (0.75) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL23529156 | 0.95 | ALDH1A1 (0.75) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL23529120 | 0.95 | ALDH1A1 (0.75) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL23529145 | 0.95 | ALDH1A1 (0.75) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR | |
| Citric Acid SCHEMBL2402384 | 0.93 | ALDH1A1 (0.71) | ALDH1A1GLRA1SLC6A9OR51E2HMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4077261-B1 | MAGNESIUM CITRATE GLYCINATE CO-SALT | JOST CHEMICAL CO (US) | 2023-06-07 | — | — | EP | disclosed |
| CN-114945551-B | Magnesium Glycine citrate co-salt | 约斯特化学公司 | 2023-03-24 | — | — | CN | disclosed |
| EP-4077261-A1 | MAGNESIUM CITRATE GLYCINATE CO-SALT | Jost Chemical Co. (US) | 2022-10-26 | — | — | EP | disclosed |
| CN-114945551-A | Magnesium citrate glycinate co-salt | 约斯特化学公司 | 2022-08-26 | — | — | CN | disclosed |
| US-11148990-B2 | Magnesium citrate glycinate co-salt | JOST CHEMICAL CO. (US) | 2021-10-19 | — | — | US | disclosed |
| US-20210188755-A1 | MAGNESIUM CITRATE GLYCINATE CO-SALT | JOST CHEMICAL CO. | 2021-06-24 | — | — | US | disclosed |
| WO-2021126549-A1 | MAGNESIUM CITRATE GLYCINATE CO-SALT | JOST CHEMICAL CO. (US) | 2021-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11148990-B2 | Magnesium citrate glycinate co-salt | SLC6A9, CA9, GRM8 | MEN1 115/4885ALDH1A1 4616/4885GLRA1 39/4885 |
| US-20210188755-A1 | MAGNESIUM CITRATE GLYCINATE CO-SALT | SLC6A9, CA9, GRM8 | MEN1 115/4885ALDH1A1 4616/4885GLRA1 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.